companydata.dkcompanydata.dk

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: Financial statements 2013

CVR: 33242840

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS (CVR 33242840) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 3,833,252 and a net result of DKK 238,375 compared with DKK 145,112 the year before. That is an increase of 75.2% compared with the year before. Equity in the 2013 report amounted to DKK 546,425. The solvency ratio was 42.2%.

Gross Profit
DKK 3,833,252
Profit/Loss
DKK 238,375
Equity
DKK 546,425
Total Assets
DKK 1,293,957

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013-3.8M238K546K-
2012-2.2M145K308K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: The 2012 annual report is outJun 19, 2013

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2012. Gross profit came to DKK 2,188,044, and the net result was DKK 145,112.

About PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Noel O´Leary. The board consists of Thomas Noel O´Leary (chair), John Sheahan and Simon Peter Hollywood. The company is owned by ICON CLINICAL (UK) LIMITED. The company has 49 employees (2026). In 2025, the company reported a gross profit of DKK 61,634,124 and a net result of DKK 3,053,580 compared with DKK 3,554,282 the year before. Equity in the 2025 report amounted to DKK 23,945,884.

Source: annual report 2025, Danish Business Authority